Synthesis and metal complexation properties of Ph-DTPA and Ph-TTHA: novel radionuclide chelating agents for use in nuclear medicine
作者:S�bastien G. Gouin、Jean-Fran�ois Gestin、Laurence Monrandeau、Fabienne Segat-Dioury、Jean Claude Meslin、David Deniaud
DOI:10.1039/b413758b
日期:——
We wish to report the synthesis and metal complexation properties of new radionuclide chelating agents for use in nuclear medicine. The strategy includes the facile preparation of rigid analogues of DTPA and TTHA possessing an aromatic ring. The aromatic structure used increased the stability of the complexes formed (pre-organization concept) and they are easily functionalised for attaching to any
The present disclosure provides for methods of diagnosing and treating bacterial infections. Human Intelectin 1 (hIntL-1) has been shown to bind selectively to glycan components on bacteria including
Streptococcus pneumonia, Proteus mirabilis, Proteus vulgaris, Klebsiella pneumonia
and
Yersinia pestis
. This interaction can be targeted to identify, purify and therapeutically target such organisms.
Es wird die Synthese des Piperazino-1′, 2′: 1,2-benzirnidazol- Ringsystems beschrieben: (a) durch Angliederung eines Piperazin- Ringes an Benzimidazol; (b) durch Ringschluss eines geeignet substituierten Piperazins zum Benzimidazol-Derivat nach der Methode von Saunders2.
合成哌嗪子-1',2':1,2-苯并达唑-环系统的反应:(b)杜林(Ringschluss)eines geeignet替代Piperazins zum Benzimidazol-Derivat nach der Methode von Saunders 2。
GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID COMPOUND OR SALT THEREOF
申请人:Glytech, Inc.
公开号:EP2924053A1
公开(公告)日:2015-09-30
[Problem] The purpose is to provide a compound containing a carrier linker moiety and a physiologically active substance moiety or a salt of the compound, wherein a carrier in the carrier linker moiety is biodegradable and is soluble in water.
[Solution] The purpose can be achieved by employing a sugar chain as a carrier and focusing on the structure of a carrier-linker having a specified structure. A compound containing a carrier linker moiety and a physiologically active substance moiety or a salt of the compound is discovered.
The present disclosure provides for methods of diagnosing and treating bacterial infections. Human Intelectin 1 (hIntL-1) has been shown to bind selectively to glycan components on bacteria including Streptococcus pneumonia, Proteus mirabilis, Proteus vulgaris, Klebsiella pneumonia and Yersinia pestis. This interaction can be targeted to identify, purify and therapeutically target such organisms.